| | | 62499 | | 06.01.2012 | | AstraZeneca AG | | | | | | | | | | | | | 02.07.20. | | | | 02.07.20. | | FI |
| | Seq.-Nr. | Präparat | Beschreibung | Galenische Form | ATC-Klassierung | |
|---|
| 01 | Pemzek PLUS 8/12.5 mg | Tabletten | Tabletten (Candesartanum Cilexetilum 8 mg, Hydrochlorothiazidum 12.5 mg) | C09DA06 | PI | | 02 | Pemzek PLUS 16/12.5 mg | Tabletten | Tabletten (Candesartanum Cilexetilum 16 mg, Hydrochlorothiazidum 12.5 mg) | C09DA06 | PI | | 03 | Pemzek PLUS 32/12.5 mg | Tabletten | Tabletten (Candesartanum Cilexetilum 32 mg, Hydrochlorothiazidum 12.5 mg) | C09DA06 | PI | | 04 | Pemzek PLUS 32/25 mg | Tabletten | Tabletten (Candesartanum Cilexetilum 32 mg, Hydrochlorothiazidum 25 mg) | C09DA06 | PI |
|
|
